Results 11 to 20 of about 19,055 (241)

Drugs in focus: Budesonide and its role in paediatric gastrointestinal disorders. [PDF]

J Pediatr Gastroenterol Nutr
Abstract Budesonide is a glucocorticoid with strong topical anti‐inflammatory properties and minimal systemic effects due to extensive first‐pass hepatic metabolism. It is designed for targeted delivery within the gastrointestinal (GI) tract and is available in oral and rectal formulations.
Aziz S, Puoti MG, Assa A, Misak Z, Mas E, Borrelli O, Dolinšek J, Martin-de-Carpi J, Scheers I, Tzivinikos C, Homan M, Strisciuglio C.   +11 more
europepmc   +2 more sources

Evaluation of the efficacy of MMX mesalazine therapy for moderate ulcerative colitis

Медицинский совет, 2021
Introduction. Treatment of patients with ulcerative colitis (UC) requires continuous anti-relapse therapy. Mesalazines are the firstline disease-modifying drugs for the treatment of mild to moderate UC to manage exacerbations and to induce and maintain ...
O. V. Knyazev, A. V. Kagramanova, A. A. Lishchinskaya   +2 more
doaj   +1 more source

Oral Microcapsule Chromocolonoscopy With Patent Blue V Improves Adenoma Detection Safely and Effectively. [PDF]

United European Gastroenterol J
ABSTRACT Background and Objective Chromocolonoscopy significantly improves polyp/adenoma detection rates (PDR/ADR). However, its integration into routine clinical practice is hindered by its cumbersome mode of application. The objective was to develop an oral nutritional grade delivery system and to assess its efficacy for colonic release, mucosal ...
Schulte B, Waetzig GH, Bethge J, Aden K, Conrad CC, Theismann EM, Keppler JK, Ruhmlieb T, Schwarz K, Schreiber S, Ellrichmann M.   +10 more
europepmc   +2 more sources

Optimization of approaches to the treatment of mild to moderate ulcerative colitis

Лечащий Врач, 2021
Ulcerative colitis is an autoimmune disease of the colon, manifested by the development of non-specific inflammation of its mucous membrane with a mandatory lesion of the rectum.
S. S. Belous, O. V. Knyazev
doaj   +1 more source

The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis

BMC Gastroenterology, 2022
Background Multi-matrix mesalazine (MMX) is an important treatment for ulcerative colitis (UC); however, it is often excreted intact, which increases the risk of relapse. This study aimed to clarify the risk factors for insoluble MMX excretion.
Ohtaki Yuichiro, Uchiyama Kan, Kamiya Hirotaka, Moriizumi Eri, Yamada Moe, Aoki Yuma, Watanabe Toshimune, Kiryu Sachie, Suzuki Sizuka, Matsumoto Yoshihiro, Ito Zensho, Ohkusa Toshifumi, Koido Shigeo, Saruta Masayuki   +13 more
doaj   +1 more source

A Case of Stevens–Johnson Syndrome Complicated with Multimatrix System Mesalamine in Ulcerative Colitis

Medicina, 2022
A 41-year-old man was treated with prednisolone (PSL) and multimatrix (MMX) mesalamine for remission induction therapy of ulcerative colitis. PSL was tapered due to successful remission induction treatment.
Mimari Kanazawa, Keiichi Tominaga, Akira Kanamori, Takanao Tanaka, Satoshi Masuyama, Shoko Watanabe, Keiichiro Abe, Akira Yamamiya, Kenichi Goda, Atsushi Irisawa   +9 more
doaj   +1 more source

Characterization of Osteoarthritis in a Medial Meniscectomy-Induced Animal Model Using Contrast-Enhanced X-ray Microtomography

Biomedicines, 2020
The aim of this study was to clarify degradation characteristics in each tissue of the knee complex of a medial meniscectomy (MMx)-induced knee osteoarthritis (KOA) animal model using classical methods and an alternative comprehensive evaluation method ...
Takehito Sugasawa, Tomoaki Kuji, Kai Aoki, Koki Yanazawa, Akiko Takenouchi, Makoto Watanabe, Yoshiya Tome, Yoshinori Takeuchi, Yuichi Aita, Naoya Yahagi, Yasuhiro Shishikura, Seiko Ono, Yasuko Yoshida, Yasushi Kawakami, Kazuhiro Takekoshi   +14 more
doaj   +1 more source

Experiencia de la vida real con el uso de mesalazina MMX en pacientes mexicanos con CUCI en dos centros de tercer nivel

Revista de Gastroenterología de México, 2022
Resumen: Introducción y objetivos: Los 5-aminosalicilatos, principalmente la mesalazina, es la primera opción de tratamiento para la colitis ulcerosa crónica idiopática (CUCI) con actividad de leve a moderada.
J.K. Yamamoto-Furusho, N.N. Parra-Holguín   +1 more
doaj   +1 more source

Comparative evaluation of the effectiveness of monotherapy of ulcerative colitis with mesalazine MMX and combination therapy with non-prolonged mesalazines with rectal forms

Медицинский совет, 2022
Introduction. According to clinical guidelines, the treatment of patients with ulcerative colitis (UC) is carried out as combination therapy with mesalazine in rectal forms.The aim was to compare the effectiveness of treatment of moderate severity UC ...
O. V. Knyazev, A. V. Kagramanova, A. A. Lishchinskaya, A. F. Babaian, T. V. Shkurko, B. A. Nanaeva, I. A. Li   +6 more
doaj   +1 more source

MIRS: an imaging spectrometer for the MMX mission

Earth, Planets and Space, 2021
The MMX infrared spectrometer (MIRS) is an imaging spectrometer onboard MMX JAXA mission. MMX (Martian Moon eXploration) is scheduled to be launched in 2024 with sample return to Earth in 2029.
Maria Antonietta Barucci, Jean-Michel Reess, Pernelle Bernardi, Alain Doressoundiram, Sonia Fornasier, Michel Le Du, Takahiro Iwata, Hiromu Nakagawa, Tomoki Nakamura, Yves André, Shohei Aoki, Takehiko Arai, Elisa Baldit, Pierre Beck, Jean-Tristan Buey, Elisabet Canalias, Matthieu Castelnau, Sebastien Charnoz, Marc Chaussidon, Fréderic Chapron, Valerie Ciarletti, Marco Delbo, Bruno Dubois, Stephane Gauffre, Thomas Gautier, Hidenori Genda, Rafik Hassen-Khodja, Gilles Hervet, Ryuki Hyodo, Christian Imbert, Takeshi Imamura, Laurent Jorda, Shingo Kameda, Driss Kouach, Toru Kouyama, Takeshi Kuroda, Hiroyuki Kurokawa, Laurent Lapaw, Jeremie Lasue, Laetitia Le Deit, Aurélien Ledot, Cedric Leyrat, Bertrand Le Ruyet, Moe Matsuoka, Frederic Merlin, Hideaki Miyamoto, Frederic Moynier, Napoleon Nguyen Tuong, Kazunori Ogohara, Takahito Osawa, Jérôme Parisot, Laurie Pistre, Benjamin Quertier, Sean N. Raymond, Francis Rocard, Takeshi Sakanoi, Takao M. Sato, Eric Sawyer, Fériel Tache, Sylvain Trémolières, Fuminori Tsuchiya, Pierre Vernazza, Didier Zeganadin   +62 more
doaj   +1 more source